Xiaolian Sun

Xiaolian Sun

Auto-generated profile, based on publicly available information

Xiaolian Sun

China Pharmaceutical University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2021 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
HLHuan Liang
Huan Liang
XWXiyao Wu
Xiyao Wu
GZGuizhen Zhao
Guizhen Zhao
KFKai Feng
Kai Feng
KNKaiyuan Ni
Kaiyuan Ni
XSXiaolian Sun
Xiaolian Sun

18 June 2019 in ACS Central Science
Verified
Journal Article
Open access
JWJiahe Wu
Jiahe Wu
FLFangyuan Li
Fangyuan Li
XHXi Hu
Xi Hu
JLJingxiong Lu
Jingxiong Lu
XSXiaolian Sun
Xiaolian Sun
Daishun LingDaishun Ling
Daishun Ling
Bacterial biofilms pose a major threat to public health because they are resistant to most current therapeutics. Conventional antibiotics exhibit limited penetration and weakened activity in the acidic microenvironment of a biofilm. Here, the development of biofilm-responsive nanoantibiotics (rAgNAs) composed of self-assembled silver nanoclusters and pH-sensitive charge reversal ligands, whose bactericidal activity can be selectively boosted in the biofilm microenvironment, is reported. Under neutral physiological conditions, the bactericidal activity of rAgNAs is self-quenched because the toxic silver ions’ release is largely inhibited; however, upon entry into the acidic biofilm microenvironment, the rAgNAs not only exhibit charge reversal to facilitate local accumulation and retention but also disassemble into small silver nanoclusters, thus enabling deep penetration and accelerated silver ions release for dramatically amplified bactericidal activity. The superior antibiofilm activity of rAgNAs is demonstrated both in vitro and in vivo, and the mortality rate of mice with multi-drug-resistant biofilm-induced severe pyomyositis can be significantly reduced by rAgNAs treatment, indicating the immense potential of rAgNAs as highly efficient nanoscale antibacterial agents to combat resistant bacterial biofilm-associated infections.

5 February 2019 in Nano Letters
Verified
Journal Article
Closed access
FLFangyuan Li
Fangyuan Li
ZLZeyu Liang
Zeyu Liang
JLJianan Liu
Jianan Liu
JSJihong Sun
Jihong Sun
XHXi Hu
Xi Hu
Daishun LingDaishun Ling
Daishun Ling

20 June 2023 in ACS Environmental Au
Verified
Journal Article
Open access
ZLZhuo Liu
Zhuo Liu
BXBiyang Xu
Biyang Xu
YJYu-Jing Jiang
Yu-Jing Jiang
YZYang Zhou
Yang Zhou
XSXiaolian Sun
Xiaolian Sun
WZWenlei Zhu
Wenlei Zhu
With 28-34 times the greenhouse effect of CO2 over a 100-year period, methane is regarded as the second largest contributor to global warming. Reducing methane emissions is a necessary measure to limit global warming to below 1.5 °C. Photocatalytic conversion of methane is a promising approach to alleviate the atmospheric methane concentrations due to its low energy consumption and environmentally friendly characteristics. Meanwhile, this conversion process can produce valuable chemicals and liquid fuels such as CH3OH, CH3CH2OH, C2H6, and C2H4, cutting down the dependence of chemical production on crude oil. However, the development of photocatalysts with a high methane conversion efficiency and product selectivity remains challenging. In this review, we overview recent advances in semiconductor-based photocatalysts for methane conversion and present catalyst design strategies, including morphology control, heteroatom doping, facet engineering, and cocatalysts modification. To gain a comprehensive understanding of photocatalytic methane conversion, the conversion pathways and mechanisms in these systems are analyzed in detail. Moreover, the role of electron scavengers in methane conversion performance is briefly discussed. Subsequently, we summarize the anthropogenic methane emission scenarios on earth and discuss the application potential of photocatalytic methane conversion. Finally, challenges and future directions for photocatalytic methane conversion are presented.

20 April 2021 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
NLNian Liu
Nian Liu
XCXiao Chen
Xiao Chen
XSXia Sun
Xia Sun
XSXiaolian Sun
Xiaolian Sun
JSJunpeng Shi
Junpeng Shi
Persistent luminescence nanoparticles (PLNPs) are unique optical materials that emit afterglow luminescence after ceasing excitation. They exhibit unexpected advantages for in vivo optical imaging of tumors, such as autofluorescence-free, high sensitivity, high penetration depth, and multiple excitation sources (UV light, LED, NIR laser, X-ray, and radiopharmaceuticals). Besides, by incorporating other functional molecules, such as photosensitizers, photothermal agents, or therapeutic drugs, PLNPs are also widely used in persistent luminescence (PersL) imaging-guided tumor therapy. In this review, we first summarize the recent developments in the synthesis and surface functionalization of PLNPs, as well as their toxicity studies. We then discuss the in vivo PersL imaging and multimodal imaging from different excitation sources. Furthermore, we highlight PLNPs-based cancer theranostics applications, such as fluorescence-guided surgery, photothermal therapy, photodynamic therapy, drug/gene delivery and combined therapy. Finally, future prospects and challenges of PLNPs in the research of translational medicine are also discussed.

1 January 2021 in Biomaterials
Verified
Journal Article
Closed access
HLHuan Liang
Huan Liang
JGJingru Guo
Jingru Guo
YSYiyue Shi
Yiyue Shi
GZGuizhen Zhao
Guizhen Zhao
SSShouheng Sun
Shouheng Sun
XSXiaolian Sun
Xiaolian Sun